Trial · NCT05007522
Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19
NCT05007522, Phase 3, Completed, Sen-Jam Pharmaceutical
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19. Trials, record NCT05007522. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05007522
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19
- NCT number
- NCT05007522
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 150 participants, actual
- Lead sponsor
- Sen-Jam Pharmaceutical
- Conditions
- COVID-19 Respiratory Infection
- Interventions
- Ketotifen/Indomethacin, Placebo
- First posted
- 2021-08-16
- Last updated
- 2024-06-24
Source ClinicalTrials.gov
Registered outcomes44
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | UCSD Shortness of Breath Questionnaire | Study Day 14 | 24-item measure that assesses self-reported shortness of breath while performing a variety of activities of daily living. |
| Secondary | Development of severe disease | 28 days | Severe disease defined as hypoxia to room air pulse oximetry below 93% |
| Secondary | Development of severe disease | 84 days | Severe disease defined as hypoxia to room air pulse oximetry below 93% |
| Secondary | Development of severe disease | 14 days | Severe disease defined as hypoxia to room air pulse oximetry below 93% |
| Secondary | Proportion and number of medically attended visits related to COVID-19 | 28 days | Need for emergency department visit or hospitalization for symptoms of COVID-19 |
| Secondary | Proportion and number of medically attended visits related to COVID-19 | 84 days | Need for emergency department visit or hospitalization for symptoms of COVID-19 |
| Secondary | Need for hospitalization | 28 days | inpatient hospitalization |
| Secondary | Need for hospitalization | 84 days | inpatient hospitalization |
| Secondary | Intensive care unit admission | 28 days | Intensive care unit admission |
| Secondary | Intensive care unit admission | 84 days | Intensive care unit admission |
1 to 10 of 44Source ClinicalTrials.gov
See all 44 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05007522
GET https://conductscience.org/api/trials/v1/NCT05007522/registered?page=2